Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
The prevalence of obstructive sleep apnea (OSA) in Americans is 9% and increasing. Increased afferent vagal activation may predispose to OSA by reducing upper airway muscle activation/patency and disrupting respiratory rhythmogenesis. Vagal afferent neurons are inhibited by cannabinoid type 1 (CB1)...
Main Authors: | Michael W Calik, David W Carley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4211887?pdf=render |
Similar Items
-
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
by: Bharati ePrasad, et al.
Published: (2013-01-01) -
Cannabinoid-induced Behavioral Sensitization in Adolescent Sprague-Dawley Rats
by: Stone, Michelle
Published: (2018) -
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
by: Parikh N, et al.
Published: (2016-10-01) -
Effiziente Synthese von Dronabinol und weiterer cannabinoider Derivate und deren pharmakologische Charakterisierung
by: Götz, Marcus Rudolf
Published: (2019) -
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
by: Oh DA, et al.
Published: (2017-01-01)